Target intelligence / Profile preview

Ribosomal protein S6 kinase A5 (RPS6KA5)

Target
RPS6KA5
Molecular classification
Enzyme, Serine/threonine-protein kinase, Transferase (phosphorylating proteins), Member of the ribosomal S6 kinase family
01

Overview

Ribosomal protein S6 kinase A5 (RPS6KA5, also called MSK1) is a serine/threonine-protein kinase encoded on human chromosome 14 and part of the ribosomal S6 kinase family. It transduces signals from mitogens and cellular stress to a range of transcription factors and histone proteins via phosphorylation. RPS6KA5 modulates gene activation, influences immune and inflammatory responses, and has been implicated in multiple pathways related to cancer biology, neurological processes, and development. Its activities are critical for proper cell signaling, transcriptional regulation, and stress-adaptive gene expression; dysregulation may influence pathologies such as cancer, inflammatory disease, and rare genetic syndromes.

Other names
RPS6KA5Ribosomal protein S6 kinase alpha-590 kDa ribosomal protein S6 kinase 5MSK1 (Mitogen- and stress-activated kinase 1)RSK-like protein kinaseRSKLS6K-alpha-5MSPK1RLPKRLSK3110005L17RIK6330404E13Rik
02

Mechanism of action

For hypothetical or investigational inhibitors, the mechanism of action could involve competitive inhibition of ATP binding, blockage of kinase activity, suppression of downstream phosphorylation events (e.g., of transcription factors, histones), and attenuation of pro-inflammatory or proliferative signaling pathways.

03

Biological functions

Signal transductionProtein phosphorylationRegulation of transcription factors (e.g., CREB1, ATF1, RELA, STAT3, ETV1)Histone modification (phosphorylation of histones H2A, H3)Regulation of inflammatory genesCell stress response (activated by mitogenic and stress stimuli)Regulation of immediate early gene expressionNeuronal cell death mediationUbiquitin ligase activity induction in TRIM7
04

Disease associations

Cancer (including breast tumor formation, based on transcription factor regulation)Inflammation (immune regulation and cytokine signaling)Neurodegenerative disease (neuronal cell death mediation)Joubert Syndrome 28Coffin-Lowry Syndrome
05

Safety considerations

Potential for off-target toxicity due to broad substrate specificityRisk of impaired immune response or tissue regenerationPossible neurological effects, given roles in neuronal cell death
06

Biomarkers

Phosphorylation levels of histone H3 (Ser-10, Ser-28) and H2A (Ser-1) in cellsPhosphorylation states of downstream transcription factors such as CREB1, ATF1, and STAT3

Beyond the preview

Go deeper on Ribosomal protein S6 kinase A5 (RPS6KA5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S6 kinase A5 (RPS6KA5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call